Rating History for Ascendis Pharma (ASND) by Citi
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/18/2026 | Eric Joseph | New Coverage | Buy (N/A) |
355.00 (N/A) |
240.50 (230.83) |
-4.02% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 5/18/2026 | Eric Joseph | New Coverage | Buy (N/A) |
355.00 (N/A) |
240.50 (230.83) |
-4.02% | Details |
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||
![]() |
|||||||